Regular follow-ups to track progress and adjust treatment as needed
Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)
Real Treatments with Real Results Lose weight up to 15-20% On average, people on semaglutide lose 15-20% of their weight in a year Video Testimonials Videos of our Happy Customers See how patients across California are navigating their weight loss journeys through InjectCos physician-guided program
After I took the survey to assess what dosage and program was right for me based on my needs and goals, Hers sent me a personalized plan
We understand that every individual's journey is unique, and we are here to support you every step of the way
A patient on 15 mg weekly might step down to 10 mg, then 7.5 mg, then 5 mg, then 2.5 mg, each for four weeks before the next reduction